C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/19 (2006.01) A61K 38/19 (2006.01) A61K 38/48 (2006.01) C07K 14/52 (2006.01) G01N 33/68 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2304827
The present invention relates to amino-terminally truncated RANTES, lacking NH2-terminal amino acids corresponding to amino acid residues 1, 1-2, 1-3 or 1- 4 of the naturally-occurring RANTES and having chemokine antagonistic activity, as well as cDNA sequences encoding them, their use in therapy and/or in diagnosis of the diseases, in which an antagonistic activity of the chemokine effects is required, and pharmaceutical compositions comprising them.
La présente invention concerne des RANTES tronqués à acide aminé terminal, ne possédant pas les acides NH¿2?-aminés terminaux correspondant aux résidus d'acides aminés 1, 1-2, 1-3 ou 1-4 des RANTES naturels et présentant une activité antagoniste de la chémokine. L'invention concerne des séquences d'ADNc codant ces composés, leur utilisation pour traiter et/ou diagnostiquer les maladies, dans lesquelles il est nécessaire d'avoir une activité antagoniste des effets de la chémokine. L'invention concerne aussi des compositions pharmaceutiques comprenant ces composés.
Proost Paul
Struyf Sofie
Van Damme Jo
Applied Research Systems Ars Holding N.v.
Kirby Eades Gale Baker
Laboratoires Serono S.a.
LandOfFree
Amino-terminally truncated rantes as chemokine antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino-terminally truncated rantes as chemokine antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino-terminally truncated rantes as chemokine antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1819495